铁死亡在阿尔茨海默病中的作用机制及研究进展

doi:10.3760/cma.j.issn.1007-1245.2024.05.001

摘要/Abstract

摘要：

阿尔茨海默病（AD）是以慢性神经炎症为特征的神经退行性疾病，在世界范围内构成了严重的医疗挑战和医疗负担。铁死亡作为一种依赖铁的细胞死亡形式，以铁积累、脂质过氧化、氨基酸代谢紊乱和不可逆的质膜破坏为特征，可能与AD的神经功能障碍有关。本文综述铁死亡通过铁代谢、脂质代谢和氨基酸代谢机制参与AD的病理进展，以及抑制铁死亡在AD中的潜在治疗措施。期望以铁死亡为切入点，为AD的发生机制和预防治疗提供新见解。

关键词:

阿尔茨海默病, 铁死亡, 铁代谢, 脂质过氧化, 进展

Abstract:

Alzheimer's disease is a neurodegenerative disease characterized by chronic neuroinflammation, and poses a serious medical challenge and burden worldwide. As an iron-dependent form of cell death characterized by iron accumulation, lipid peroxidation, disturbance of amino acid metabolism, and irreversible disruption of the plasma membrane. Ferroptosis may be associated with neurological dysfunction in Alzheimer's disease. This article reviews the role of ferroptosis in the pathologic progression of Alzheimer's disease through iron, lipid, and amino acid metabolisms, and the potential therapeutic measures for inhibiting ferroptosis in Alzheimer's disease. It is expected that ferroptosis will provide new insights into the pathogenesis and preventive treatment of Alzheimer's disease.

Key words:

Alzheimer's disease, Ferroptosis, Iron metabolism, Lipid peroxidation, Progress

郑梅陆颖木大为.

铁死亡在阿尔茨海默病中的作用机制及研究进展 [J]. 国际医药卫生导报, 2024, 30(5): 705-709.

Zheng Mei, Lu Ying, Mu Dawei.

Research progress on mechanism of ferroptosis in Alzheimer's disease [J]. International Medicine and Health Guidance News, 2024, 30(5): 705-709.

参考文献

[1] Knopman DS, Amieva H, Petersen RC, et al. Alzheimer disease[J].Nat Rev Dis Primers,2021,7(1):33.DOI:10.1038/s41572-021-00269-y.
[2] Ma H, Dong Y, Chu Y, et al. The mechanisms of ferroptosis and its role in alzheimer's disease[J].Front Mol Biosci,2022,9:965064.DOI:10.3389/fmolb.2022.965064.
[3] Dixon SJ, Lemberg KM, Lamprecht MR, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death[J].Cell,2012,149(5):1060-1072.DOI:10.1016/j.cell.2012.03.042.
[4] Lill R, Srinivasan V, Mühlenhoff U. The role of mitochondria in cytosolic-nuclear iron–sulfur protein biogenesis and in cellular iron regulation[J].Curr Opin Microbiol,2014,22:111-119.DOI:10.1016/j.mib.2014.09.015.
[5] Gudjoncik A, Guenancia C, Zeller M, et al. Iron, oxidative stress, and redox signaling in the cardiovascular system[J].Mol Nutr Food Res,2014,58(8):1721-1738.DOI:10.1002/mnfr.201400036.
[6] Tang M, Chen Z, Wu D, et al. Ferritinophagy/ferroptosis: iron-related newcomers in human diseases[J].J Cell Physiol,2018,233(12):9179-9190.DOI:10.1002/jcp.26954.
[7] Hou W, Xie Y, Song X, et al. Autophagy promotes ferroptosis by degradation of ferritin[J].Autophagy,2016,12(8):1425-1428.DOI:10.1080/15548627.2016.1187366.
[8] Han X. Lipidomics for studying metabolism[J].Nat Rev Endocrinol,2016,12(11):668-679.DOI:10.1038/nrendo.2016.98.
[9] Zheng J, Conrad M. The metabolic underpinnings of ferroptosis[J].Cell Metab,2020,32(6):920-937.DOI:10.1016/j.cmet.2020.10.011.
[10] Dixon SJ, Winter GE, Musavi LS, et al. Human haploid cell genetics reveals roles for lipid metabolism genes in nonapoptotic cell death[J].ACS Chem Biol,2015,10(7):1604-1609.DOI:10.1021/acschembio.5b00245.
[11] Doll S, Proneth B, Tyurina YY, et al. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition[J].Nat Chem Biol,2017,13(1):91-98.DOI:10.1038/nchembio.2239.
[12] Chen H, Qi Q, Wu N, et al. Aspirin promotes RSL3-induced ferroptosis by suppressing mTOR/SREBP-1/SCD1-mediated lipogenesis in PIK3CA-mutant colorectal cancer[J].Redox Biol,2022,55:102426.DOI:10.1016/j.redox.2022.102426.
[13] Shintoku R, Takigawa Y, Yamada K, et al. Lipoxygenase-mediated generation of lipid peroxides enhances ferroptosis induced by erastin and RSL3[J].Cancer Sci,2017,108(11):2187-2194.DOI:10.1111/cas.13380.
[14] 程峰,张庸,王祥,等. 谷胱甘肽过氧化物酶GPX4在铁死亡中的作用与机制研究进展[J]. 现代肿瘤医学,2021,29(7):1254-1258.DOI:10.3969/j.issn.1672-4992.2021.07.033.
[15] Koppula P, Zhang Y, Zhuang L, et al. Amino acid transporter SLC7A11/xCT at the crossroads of regulating redox homeostasis and nutrient dependency of cancer[J].Cancer Commun (Lond),2018,38(1):12.DOI:10.1186/s40880-018-0288-x.
[16] Jiang L, Hickman JH, Wang SJ, et al. Dynamic roles of p53-mediated metabolic activities in ROS-induced stress responses[J].Cell Cycle,2015,14(18):2881-2885.DOI:10.1080/15384101.2015.1068479.
[17] Bersuker K, Hendricks JM, Li Z, et al. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis[J].Nature,2019,575(7784):688-692.DOI:10.1038/s41586-019-1705-2.
[18] Doll S, Freitas FP, Shah R, et al. FSP1 is a glutathione-independent ferroptosis suppressor[J].Nature,2019,575(7784):693-698.DOI:10.1038/s41586- 019-1707-0.
[19] Mao C, Liu X, Zhang Y, et al. DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer[J].Nature,2021,593(7860):586-590.DOI:10.1038/s41586-021- 03539-7.
[20] Kraft VAN, Bezjian CT, Pfeiffer S, et al. GTP cyclohydrolase 1/tetrahydrobiopterin counteract ferroptosis through lipid remodeling[J].ACS Cent Sci,2020,6(1):41-53.DOI:10.1021/acscentsci.9b01063.
[21] Bao WD, Pang P, Zhou XT, et al. Loss of ferroportin induces memory impairment by promoting ferroptosis in Alzheimer's disease[J].Cell Death Differ,2021,28(5):1548-1562.DOI:10.1038/s41418-020-00685-9.
[22] Park MW, Cha HW, Kim J, et al. NOX4 promotes ferroptosis of astrocytes by oxidative stress-induced lipid peroxidation via the impairment of mitochondrial metabolism in alzheimer's diseases[J].Redox Biol,2021,41:101947.DOI:10.1016/j.redox.2021.101947.
[23] Hambright WS, Fonseca RS, Chen L, et al. Ablation of ferroptosis regulator glutathione peroxidase 4 in forebrain neurons promotes cognitive impairment and neurodegeneration[J].Redox Biol,2017,12:8-17.DOI:10.1016/j.redox.2017.01.021.
[24] Ashraf A, Jeandriens J, Parkes HG, et al. Iron dyshomeostasis, lipid peroxidation and perturbed expression of cystine/glutamate antiporter in Alzheimer's disease: evidence of ferroptosis[J].Redox Biol,2020,32:101494.DOI:10.1016/j.redox.2020.101494.
[25] Ramos P, Santos A, Pinto NR, et al. Iron levels in the human brain: a post-mortem study of anatomical region differences and age-related changes[J].J Trace Elem Med Biol,2014,28(1):13-17.DOI:10.1016/j.jtemb.2013.08.001.
[26] Duce JA, Tsatsanis A, Cater MA, et al. Iron-export ferroxidase activity of β-amyloid precursor protein is inhibited by zinc in Alzheimer's disease[J].Cell,2010,142(6):857-867.DOI:10.1016/j.cell.2010.08.014.
[27] Belaidi AA, Gunn AP, Wong BX, et al. Marked age-related changes in brain iron homeostasis in amyloid protein precursor knockout mice[J].Neurotherapeutics,2018,15(4):1055-1062.DOI:10.1007/s13311-018-0656-x.
[28] Ashraf A, So PW. Spotlight on ferroptosis: iron-dependent cell death in Alzheimer's disease[J].Front Aging Neurosci,2020,12:196.DOI:10.3389/fnagi.2020.00196.
[29] Zhou ZD, Tan EK. Iron regulatory protein (IRP)-iron responsive element (IRE) signaling pathway in human neurodegenerative diseases[J].Mol Neurodegener,2017,12(1):75.DOI:10.1186/s13024-017-0218-4.
[30] Wan W, Cao L, Kalionis B, et al. Iron deposition leads to hyperphosphorylation of tau and disruption of insulin signaling[J].Front Neurol,2019,10:607.DOI:10.3389/fneur.2019.00607.
[31] Sultana R, Perluigi M, Butterfield DA. Lipid peroxidation triggers neurodegeneration: a redox proteomics view into the Alzheimer disease brain[J].Free Radic Biol Med,2013,62:157-169.DOI:10.1016/j.freeradbiomed.2012.09.027.
[32] Ferré-González L, Peña-Bautista C, Baquero M, et al. Assessment of lipid peroxidation in Alzheimer's disease differential diagnosis and prognosis[J].Antioxidants (Basel),2022,11(3):551.DOI:10.3390/antiox11030551.
[33] Zhang H, Morgan TE, Forman HJ. Age-related alteration in HNE elimination enzymes[J].Arch Biochem Biophys,2021,699:108749.DOI:10.1016/j.abb.2020.108749.
[34] Dare LR, Garcia A, Soares CB, et al. The reversal of memory deficits in an Alzheimer's disease model using physical and cognitive exercise[J].Front Behav Neurosci,2020,14:152.DOI:10.3389/fnbeh.2020.00152.
[35] Yang WS, Stockwell BR. Ferroptosis: death by lipid peroxidation[J].Trends Cell Biol,2016,26(3):165-176.DOI:10.1016/j.tcb.2015.10.014.
[36] Bok E, Leem E, Lee BR, et al. Role of the lipid membrane and membrane proteins in tau pathology[J].Front Cell Dev Biol,2021,9:653815.DOI:10.3389/fcell.2021.653815.
[37] Zhang Y, Wang M, Chang W. Iron dyshomeostasis and ferroptosis in Alzheimer's disease: molecular mechanisms of cell death and novel therapeutic drugs and targets for AD[J].Front Pharmacol,2022,13:983623.DOI:10.3389/fphar.2022.983623.
[38] D'Ezio V, Colasanti M, Persichini T. Amyloid-β 25-35 induces neurotoxicity through the up-regulation of astrocytic system Xc[J].Antioxidants (Basel),2021,10(11):1685.DOI:10.3390/antiox10111685.
[39] Wang C, Chen S, Guo H, et al. Forsythoside a mitigates Alzheimer's-like pathology by inhibiting ferroptosis-mediated neuroinflammation via Nrf2/GPX4 axis activation[J].Int J Biol Sci,2022,18(5):2075-2090.DOI:10.7150/ijbs.69714.
[40] Li X, Chen J, Feng W, et al. Berberine ameliorates iron levels and ferroptosis in the brain of 3 × Tg-AD mice[J].Phytomedicine,2023,118:154962.DOI:10.1016/j.phymed.2023.154962.
[41] Momiyama Y. Serum coenzyme Q10 levels as a predictor of dementia in a Japanese general population[J].Atherosclerosis,2014,237(2):433-434.DOI:10.1016/j.atherosclerosis.2014.08.056.
[42] Jiménez-Jiménez FJ, Alonso-Navarro H, García-Martín E, et al. Coenzyme Q10 and dementia: a systematic review[J].Antioxidants (Basel),2023,12(2):533.DOI:10.3390/antiox12020533.
[43] Fawzi SF, Menze ET, Tadros MG. Deferiprone ameliorates memory impairment in scopolamine-treated rats: the impact of its iron-chelating effect on β-amyloid disposition[J].Behav Brain Res,2020,378:112314.DOI:10.1016/j.bbr.2019.112314.
[44] Nolan JM, Power R, Howard AN, et al. Supplementation with carotenoids, omega-3 fatty acids, and vitamin E has a positive effect on the symptoms and progression of Alzheimer's disease[J].J Alzheimers Dis,2022,90(1):233-249.DOI:10.3233/JAD-220556.
[45] Farina N, Llewellyn D, Isaac MGEKN, et al. Vitamin E for Alzheimer's dementia and mild cognitive impairment[J].Cochrane Database Syst Rev,2017,4(4):CD002854.DOI:10.1002/14651858.CD002854.pub5.
[46] Kryscio RJ, Abner EL, Caban-Holt A, et al. Association of antioxidant supplement use and dementia in the prevention of Alzheimer's disease by vitamin E and selenium trial (PREADViSE)[J].JAMA Neurol,2017,74(5):567-573.DOI:10.1001/jamaneurol.2016.5778.
[47] Zhang YH, Wang DW, Xu SF, et al. α-lipoic acid improves abnormal behavior by mitigation of oxidative stress, inflammation, ferroptosis, and tauopathy in P301S tau transgenic mice[J].Redox Biol,2018,14:535-548.DOI:10.1016/j.redox.2017.11.001.
[48] Greenough MA, Lane DJR, Balez R, et al. Selective ferroptosis vulnerability due to familial Alzheimer's disease presenilin mutations[J].Cell Death Differ,2022,29(11):2123-2136.DOI:10.1038/s41418-022-01003-1.